INTCO Medical Honored with the Jing Chao Awards of 2025 for ESG Value

Recently, INTCO Medical (300677.SZ) was awarded the Jing Chao Awards of 2025 – ESG Value Listed Company, in recognition of its outstanding performance and sustained value creation in the areas of Environmental, Social, and Governance (ESG).

The award is jointly presented by leading domestic financial media and capital market evaluation institutions, aiming to recognize listed companies that demonstrate excellence in sustainable development, corporate governance, and long-term value creation.

This recognition once again affirms INTCO Medical’s industry-leading position in promoting high-quality corporate development and fulfilling social responsibilities, earning broad acknowledgment from both the capital market and society at large.

As a global leader in medical consumables and medical devices, INTCO Medical has long embedded ESG principles into its overall corporate strategy. The company has established a comprehensive and systematic sustainability framework that spans the entire management and operational value chain.

INTCO Medical has consistently published annual ESG reports for multiple consecutive years, enhancing transparency and strengthening trust among stakeholders. In alignment with China’s “Dual Carbon” goals, the company actively advances green manufacturing and low-carbon technologies, achieving continuous reductions in product lifecycle carbon emissions and increasing the utilization of renewable energy. These efforts have enabled INTCO Medical to deliver multiple low-carbon development achievements ahead of the industry, demonstrating the deep integration of sustainable technological innovation and green manufacturing.

In terms of social responsibility and employee well-being, INTCO Medical upholds the core values of “compassion, integrity, and truth.” The company fosters an inclusive and equitable corporate culture while continuously improving its employee development systems. Through diverse employee care initiatives and training programs, INTCO Medical enhances workforce engagement and organizational cohesion.

At the same time, the company actively participates in public welfare initiatives, contributing resources to community health education, charitable programs, and industrial poverty alleviation, thereby fulfilling its role as a responsible corporate citizen with tangible social impact.

From a corporate governance perspective, INTCO Medical adheres to modern governance principles, strengthens internal control and compliance management, and ensures transparent information disclosure and well-functioning board operations. These practices provide a solid institutional foundation for the company’s long-term and stable growth.

In recent years, as ESG evaluation systems in the capital market continue to mature, INTCO Medical has consistently achieved strong results in multiple authoritative domestic and international ESG ratings, further enhancing its global sustainability influence.

The Jing Chao Awards of 2025 – ESG Value Listed Company honor not only recognizes INTCO Medical’s past achievements in sustainable development, but also reflects strong confidence in its future strategic direction and value creation capabilities.

Moving forward, INTCO Medical will take this recognition as a new starting point, further integrating ESG principles into corporate development, promoting the coordinated advancement of environmental protection, social responsibility, corporate governance, and business value, and contributing to a more resilient and sustainable future for both the industry and society.